Duke University: Lymphoma trials

The registry lists 12 Lymphoma studies with Duke University as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06371768Not applicable
• Mobile Health Case Management System for Reducing Pediatric Treatment AbandonmentCompletedNCT03677128Not applicableResults posted
• Zevalin and Velcade in Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01497275Phase 2Results posted
• Reduced Radiation in Patients With Diffuse Large B-cell LymphomaCompletedNCT01186978Not applicableResults posted
• Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone LymphomaTerminatedNCT01121757Phase 2Results posted
• Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins LymphomaCompletedNCT00577629Phase 2Results posted
• DepoCyt for Active Lymphomatous or Leukemic MeningitisTerminatedNCT00523939Phase 2Results posted
• Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular LymphomaTerminatedNCT00510887Phase 2Results posted
• Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell LymphomaCompletedNCT00586755Phase 2
• Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain TumorCompletedNCT00006342
• Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic CancerWithdrawnNCT00003435Phase 1
• Melphalan in Patients With Neoplastic MeningitisCompletedNCT00002750Phase 1